Cargando…
Kinetics of SARS-CoV-2 antibody responses pre-COVID-19 and post-COVID-19 convalescent plasma transfusion in patients with severe respiratory failure: an observational case–control study
AIMS: While the SARS-CoV-2 pandemic may be contained through vaccination, transfusion of convalescent plasma (CCP) from individuals who recovered from COVID-19 (CCP) is considered an alternative treatment. We investigate if CCP transfusion in patients with severe respiratory failure increases plasma...
Autores principales: | Klein, Matthew N, Wang, Elizabeth Wenqian, Zimand, Paul, Beauchamp, Heather, Donis, Caitlin, Ward, Matthew D, Martinez-Hernandez, Aidaelis, Tabatabai, Ali, Baddley, John W, Bloch, Evan M, Mullins, Kristin E, Fontaine, Magali J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072701/ https://www.ncbi.nlm.nih.gov/pubmed/33893156 http://dx.doi.org/10.1136/jclinpath-2020-207356 |
Ejemplares similares
-
COVID-19 convalescent plasma transfusion
por: Langhi, Dante Mário, et al.
Publicado: (2020) -
Convalescent plasma to treat COVID-19
por: Bloch, Evan M.
Publicado: (2020) -
Treatment of COVID-19: Perspective on Convalescent Plasma Transfusion
por: Farhat, Ryan M., et al.
Publicado: (2020) -
Convalescent plasma transfusion for pregnant patients with COVID-19
por: Mastroianni, Antonio, et al.
Publicado: (2021) -
Limitations of Safety Update on Convalescent Plasma Transfusion in COVID-19 Patients
por: Farag, Youssef M.K.
Publicado: (2020)